VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2011

Jul 14, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2011-07-13

Reporting Person: Wysenski Nancy (EVP, Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-13	Stock Option	$51.75	A	36250	Acquired	2021-07-12	Common Stock (36250)	Direct

Footnotes

F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/13/2011.